Evidence map›Paper›PMID 29532622›Full record

ArticleThoracic cancer2018

Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer.

Banglun Qian, Xiang Wang, Chao Mao, Yiqun Jiang, Ying Shi, Ling Chen, Shuang Liu, Bin Wang, Shu Pan, Yongguang Tao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of molecular sciences · 2022
    Article
  4. Article
  5. Article
  6. LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Banglun QianDepartment of Thoracic Surgery, Second Xiangya Hospital of Central South University, Hunan, China.
Xiang WangDepartment of Thoracic Surgery, Second Xiangya Hospital of Central South University, Hunan, China.
Chao MaoKey Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, China.
Yiqun JiangKey Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, China.
Ying ShiKey Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, China.
Ling ChenKey Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, China.
Shuang LiuInstitutes of Medical Sciences, Xiangya Hospital, Central South University, Hunan, China.
Bin WangDepartment of Thoracic Surgery, Second Xiangya Hospital of Central South University, Hunan, China.
Shu PanDepartment of Thoracic Surgery, Second Xiangya Hospital of Central South University, Hunan, China.
Yongguang TaoDepartment of Thoracic Surgery, Second Xiangya Hospital of Central South University, Hunan, China.ORCID 0000-0003-2354-5321
Hongcan ShiDepartment of Cardiothoracic Surgery, Clinical College of Yangzhou University, Jiangsu, China.
Central South University · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor many years, lung cancer has been the most common and deadly cancer worldwide. Early diagnosis of non-small cell lung cancer (NSCLC) in particular is very difficult because the symptoms are often ignored. The five-year survival rate is very low despite great improvements to therapy. Thus, there is an urgent need to identify prognostic biomarkers and target molecules for the clinical diagnosis and individualized treatment of NSCLC.

methodsWe performed quantitative real-time PCR to determine the expression levels of the long non-coding RNA (lncRNA) linc01433 in NSCLC and normal matched lung tissue. Subsequently, we established cell lines with overexpression or knockdown of linc01433 to evaluate the effects on proliferation and metastasis in vitro. Epithelial-to-mesenchymal transition was examined using Western blot.

resultsLinc01433 was significantly overexpressed in NSCLC tissues compared to normal lung tissues. In addition, linc01433 levels were associated with smoking history. Linc01433 overexpression in lung cancer cells increased proliferation, migration, and invasion abilities, as well as epithelial-to-mesenchymal transition.

conclusionsLinc01433 is a cancer-related lncRNA that may have an oncogene-like effect in NSCLC.

Indexed as

AdultAgedBiomarkers, TumorCarcinoma, Non-Small-Cell LungCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingBiomarkers, TumorRNA, Long NoncodinglncRNAmetastasismigration and invasionNSCLCprognostic marker

Identifiers

PMID29532622
PMCPMC5928388
OpenAlexW2796837488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.